WHO WE ARE

We aim to improve the quality of life everyone
  • 2020
    • Release preparation for new product line (TBA)
    • SKIN ACTUALLY water essence cosmetic release
      Patent registration for SPM technology (United States)
  • 2019
    • Release preparation for cosmetic product
    • Establishment of Biocoz Global Research and Development Center
  • 2018
    • SPM™ investigator-led test by Dr. Ju Hee Lee (Severance Hospital) with positive results
    • Dermatology clinic targeted DERM ACTUALLY cosmetic release
    • Establishment of US branch corporation, BIOCOZ GLOBAL INC.
  • 2017
    • Commencement of SPM™ investigator-led test by Dr. Ju Hee Lee (Severance Hospital)
    • Certificate supporting the safety and efficacy of SPM™ released by Dr. Martin C. Mihm Jr. (Harvard Medical School).
    • Patent registration for SPM™ technology (Republic of Korea)
  • 2016
    • Commencement of in vivo studies led by Dr. Martin C. Mihm Jr., M.D. (Harvard Medical School)
    • Dr. Martin C. Mihm Jr. appointed as the Head of Medical Advisory Board at Biocoz Global
  • 2015
    • Validation of in vitro study results by Dr. Anthony J. Sinskey, Ph.D. (Massachusetts Institute of Technology)
    • Dr. Anthony J. Sinskey, Ph.D. appointed as Head of Scientific Advisory Board at Biocoz Global
    • Completion of SPM™ formula by Dr. Chanhwa Kim, Ph.D. (Korea University)
  • 2011
    • Establishment of Singapore head corporation, BIOCOZ GLOBAL Pte. Ltd.
    • Establishment of South Korea branch corporation, BIOCOZ GLOBAL Korea Corp.
    • Development of bioactive composition prototype
    • Initiation of cell activating material studies in South Korea (Dr. Chanwha Kim, Ph.D., Korea University)
  • 2006
    • Initiation of cell growth activating material studies (Dr. Phan Toan Thang, M.D., Ph.D., National University Singapore)